Cargando…
shp-2 gene knockout upregulates CAR-driven cytotoxicity of YT NK cells
In Russia, cancer is the second leading cause of death following cardiovascular diseases. Adoptive transfer of NK cells is a promising approach to fight cancer; however, for their successful use in cancer treatment, it is necessary to ensure their robust accumulation at tumor foci, provide resistanc...
Autores principales: | Subrakova, V.G., Kulemzin, S.V., Belovezhets, T.N., Chikaev, A.N., Chikaev, N.A., Koval, O.A., Gorchakov, A.A., Taranin, A.V. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
The Federal Research Center Institute of Cytology and Genetics of Siberian Branch of the Russian Academy of Sciences
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7716529/ https://www.ncbi.nlm.nih.gov/pubmed/33659784 http://dx.doi.org/10.18699/VJ20.598 |
Ejemplares similares
-
VEGFR2-specific FnCAR effectively redirects the cytotoxic activity of T cells and YT NK cells
por: Kulemzin, Sergey V., et al.
Publicado: (2018) -
Design and analysis of stably integrated reporters for inducible transgene expression in human T cells and CAR NK-cell lines
por: Kulemzin, Sergey V., et al.
Publicado: (2019) -
Horses for Courses in the Era of CARs: Advancing CAR T and CAR NK Cell Therapies
por: Kulemzin, Sergey, et al.
Publicado: (2021) -
Memory B Cells Induced by Sputnik V Vaccination Produce SARS-CoV-2 Neutralizing Antibodies Upon Ex Vivo Restimulation
por: Byazrova, Maria G., et al.
Publicado: (2022) -
VH3-53/66-Class RBD-Specific Human Monoclonal Antibody iB20 Displays Cross-Neutralizing Activity against Emerging SARS-CoV-2 Lineages
por: Kulemzin, Sergey V., et al.
Publicado: (2022)